Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Maculopathy, Age-Related”

1,428 trials

Showing 20 of 1,428 results

Not applicableActive Not RecruitingNCT05735730
What this trial is testing

Can the Risk for AMD be Modulated?

Who this might be right for
Age-Related Macular Degeneration (ARMD)
Association for Innovation and Biomedical Research on Light and Image 1,800
Large-scale testing (Phase 3)Temporarily pausedNCT00460967
What this trial is testing

Safety and Effectiveness Investigation for Dry, Non-Exudative Age Related Macular Degeneration (AMD) Using Rheopheresis

Who this might be right for
Age-Related Maculopathy
OccuLogix 325
Not applicableActive Not RecruitingNCT04065490
What this trial is testing

Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE III)

Who this might be right for
Dry Age-related Macular Degeneration
LumiThera, Inc. 96
Testing effectiveness (Phase 2)Study completedNCT02462889
What this trial is testing

IAI Versus Sham as Prophylaxis Against Conversion to Neovascular AMD

Who this might be right for
Age-Related Macular Degeneration
Jeffrey S Heier 128
Not applicableStudy completedNCT02395757
What this trial is testing

Microperimetry and Eye Progressing From Stage 3 to Stage 4 Age-related Macular Degeneration (AMD)

Who this might be right for
Stage 3 Age Related Macular Degeneration (AREDS Classification)
Hospices Civils de Lyon 182
Testing effectiveness (Phase 2)Ended earlyNCT00414206
What this trial is testing

Safety and Efficacy of ATG003 in Patients With Wet Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
CoMentis 343
Large-scale testing (Phase 3)UnknownNCT04572698
What this trial is testing

Compare LY09004 and Eylea in the Treatment of Wet Age-related Macular Degeneration（wAMD）

Who this might be right for
Age Related Macular Degeneration
Luye Pharma Group Ltd. 416
Early research (Phase 1)Study completedNCT01835015
What this trial is testing

Pharmacokinetics of CLG561 in Patients With Advanced Age-Related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Alcon Research 50
Early research (Phase 1)Temporarily pausedNCT02452385
What this trial is testing

Phase 1 Study of CM082 in Patients With wAMD

Who this might be right for
Age-Related Macular Degeneration
AnewPharma 56
Not applicableStudy completedNCT01464710
What this trial is testing

Genetic Assessment of Early to Late Macular Degeneration Study

Who this might be right for
Age-related Macular Degeneration
Henry Ferreyra 170
Testing effectiveness (Phase 2)Ended earlyNCT01603043
What this trial is testing

A Multicenter, Proof-Of-Concept Study Of Intravitreal AL-78898A In Patients With Geographic Atrophy (GA) Associated With Age-Related Macular Degeneration (AMD)

Who this might be right for
Geographic Atrophy
Alcon Research 10
Not applicableStudy completedNCT01010997
What this trial is testing

Foresee Home for Monitoring Age Related Macular Degeneration (AMD)

Who this might be right for
Age Related Macular Degeneration
Notal Vision Ltd. 10
Not applicableStudy completedNCT03418220
What this trial is testing

Comparison of Cytokine Profiles in Aqueous Humor of Patients With Age Related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration, Age-Related
Hospices Civils de Lyon 82
Not applicableStudy completedNCT00359008
What this trial is testing

PHP Home Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization (CNV)

Who this might be right for
Age Related Macular Degeneration
Notal Vision Ltd. 336
Early research (Phase 1)UnknownNCT04468997
What this trial is testing

The Study of Drug 601 in Patients With Wet Age-related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 67
Not applicableStudy completedNCT00088192
What this trial is testing

Intravitreous Pegaptanib Sodium Injection in Patients With Exudative Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
Eyetech Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT01327222
What this trial is testing

Intravitreal Bevacizumab for Low Vision in Neovascular Age-related Macular Degeneration (AMD)

Who this might be right for
Age Related Macular Degeneration
IRCCS San Raffaele 20
Not applicableEnded earlyNCT05266495
What this trial is testing

Effectiveness of Brolucizumab in Pre-treated Patients With nAMD in the Real-world Setting

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 3
Testing effectiveness (Phase 2)Study completedNCT03744767
What this trial is testing

Adjuvant Anti-Mineralocorticoid-Receptor Treatment in Anti-VEGF Refractory Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Dr Irmela MANTEL 20
Not applicableStudy completedNCT04482465
What this trial is testing

Omega 3 and Vitamin D Dosage in a Population With Moderate to High Risk of AMD

Who this might be right for
Age-related Macular DegenerationVitamin D Deficiency
Universitaire Ziekenhuizen KU Leuven 50
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation